Recombinant HGF, the ligand for Met, suppressed the progression in a mouse model of NASH, and MSP negatively regulated inflammation and lipogenesis in ex vivo models of NASH [54,106,107]. Here, MET is linked to metabolic dysfunction-associated steatohepatitis.